‘New GSK’ Still Has Some Convincing To Do

Vaccine And Speciality Medicines The Focus

 
• By Andrew McConaghie
  
GSK syringes
The 'New GSK' aims to deliver growth from its vaccines and speciality medicines pipeline, plus a steady but flat income from established general medicines. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip